Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model
Authors
Keywords
Mouse models, Atherosclerosis, MicroRNAs, Lipids, Oxidative stress, Inflammation, Aorta, Cytokines
Journal
PLoS One
Volume 9, Issue 6, Pages e99849
Publisher
Public Library of Science (PLoS)
Online
2014-06-17
DOI
10.1371/journal.pone.0099849
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Notoginsenoside R1-mediated neuroprotection involves estrogen receptor-dependent crosstalk between Akt and ERK1/2 pathways: A novel mechanism of Nrf2/ARE signaling activation
- (2014) X. Meng et al. FREE RADICAL RESEARCH
- Protective effects of Notoginsenoside R1 on intestinal ischemia-reperfusion injury in rats
- (2013) Chong Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Panax Notogingseng Saponins Suppress RAGE/ MAPK Signaling and NF-kappaB Activation in Apolipoprotein-E-deficient Atherosclerosis-prone mice
- (2013) Lin Dou et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Oxidative stress in atherosclerosis: The role of microRNAs in arterial remodeling
- (2013) Anna Zampetaki et al. FREE RADICAL BIOLOGY AND MEDICINE
- microRNA Regulation of Inflammatory Responses
- (2012) Ryan M. O'Connell et al. Annual Review of Immunology
- Cardiovascular disease risk reduction by raising HDL cholesterol - current therapies and future opportunities
- (2012) K Mahdy Ali et al. BRITISH JOURNAL OF PHARMACOLOGY
- Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling
- (2012) Bing Sun et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inflammation in atherosclerosis: a cause or a result of vascular disorders?
- (2012) Ileana Manduteanu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis
- (2011) Maarten Hulsmans et al. FASEB JOURNAL
- MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts
- (2010) Liang Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Short Communication: Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21–Dependent Mechanism
- (2010) Felix Fleissner et al. CIRCULATION RESEARCH
- MicroRNA-26a is a novel regulator of vascular smooth muscle cell function
- (2010) Nicholas J. Leeper et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis
- (2010) Sudarshan Anand et al. NATURE MEDICINE
- NOTOGINSENOSIDE R1 ATTENUATES RENAL ISCHEMIA-REPERFUSION INJURY IN RATS
- (2010) Wen-Jun Liu et al. SHOCK
- MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages
- (2009) Ting Chen et al. CARDIOVASCULAR RESEARCH
- Panax notoginseng Reduces Atherosclerotic Lesions in ApoE-Deficient Mice and Inhibits TNF-α-Induced Endothelial Adhesion Molecule Expression and Monocyte Adhesion
- (2009) Jian-Bo Wan et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation
- (2009) A R R Forrest et al. LEUKEMIA
- MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
- (2009) A. Bonauer et al. SCIENCE
- Effects of four medicinal herbs on human vascular endothelial cells in culture
- (2007) Shanhong Ling et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started